Monensin and forskolin inhibit the transcription rate of sucrase-isomaltase but not the stability of its mRNA in Caco-2 cells  by Chantret, I. et al.
Volume 328, number I,.& 55-58 FEBS 12796 
0 1993 Federation of European Biochemical Societies #0145793/93/S6.00 
August 1993 
Monensin and forskolin inhibit the transcription rate of 
§~~ras~-isom~ltase but not the stability of its mRNA in Caco-2 cells 
I. Chantret”, M. Lacasab, G. Chevalier”, D. Swallow” and M. Rousset” 
‘i.kit& de Recherches SUP lu Differenciatio~r Celiulaire Intestirtale, IAJSERM Ui 78, 16 uverrue PC&- Vaillunt Couturier, 94807 yirrejuif 
Cedex, .Fw~ce, ‘IRSC t~a~orut~~ire Vi us et ~l~~re~~iat~on~ 7 rue CUT Mo~llet~ 9480 V~lleju~~ France and ~r~~~~ersit~ Pierre et Marie 
Curie, 4 Place Jussieu, 75005 Paris, France and “MRC Human biochemical Geswtics Unit, The Walton La~i~rator~. university College 
London, 4 Stephenson Way, Lortdon, NW1 2HE. UK 
Received 21 May 1993; revised version received 16 June 1993 
Treatment of Caco-2 cells with forskohn (25 yM) or monensin (I PM) has previously been shown to cause a marked decrease m the level of 
su~rase--isomaltase (SI) mRNA, without any effect on the expresston ofdlpeptidylpeptldase IV (DPP-IV). In the present work, we report that there 
1s no significant difference in the stabihty of SI mRNA between control and treated cells. On the other hand. we demonstrate a decrease in the 
transcription rate of SI mRNA which is sufficient to account for the decrease m the steady-state level of SI mRNA both in forskolm- and 
mo~ensin-treated Caco-2 cells. 
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I. INTRODUCTION 
We have previously shown that, in Cam-2 cells. fors- 
kolin (35pUM) and monensin (1 ,&I), in addition to their 
classical effects which are, respectively, an activation of 
adenylate cyclase (11 and an alteration of distal Golgi 
functions 121, cause a modi~cation of glucose metabo- 
lism and a decreased expression of the intestinal hydro- 
lase, sucrase-isomaltase (SE) 13-71. The repression of SI 
characterized by a significant reduction in its biosynthe- 
sis is due to a dramatic decrease of its mRNA level [&8], 
This effect appears to be specific to SI: the mRNA level 
and the biosynthesis of another brush border hydrolase, 
dipeptidylpeptidase IV (DPP IV), is not affected 14.71. 
Although the human SI gene has been cloned [X,9], very 
little is known about its regulation. Regulatioll of ex- 
pression of eukaryotic genes at the level of mRNA can 
occur in various ways, of which the more common are: 
trancsription rate [IO], alternative splicing [l 11, and sta- 
bility of mRNA [13]. Alternative splicing of the SI gene 
in forskolin- or monensin-treated Caco-2 cells seemed 
very unlikely since we have never observed differences 
in the size of SI mRNA in these cells [S-S]. The aim of 
this work was, therefore, to investigate whether the de- 
crease of SI mRNA in forskolin- and monensin-related 
Caco-2 cells was due to a decrease of the stability of SI 
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mRNA, or a decrease of the transription rate of the ST 
gene, or a combination of both processes. 
2. MATERIALS AND METHODS 
Control Caco-2 cells or Caco-2 cells treated for 48 h with 25 PM 
forskolm or I FM monens~n were assayed at day 16 after platmg as 
previously reported [5,6]. Northern blot analysis. stab&y and nuclear 
run-on studies were performed on triphcate cultures of Caco-2 cells. 
Extraction of RNA and Northern blot analysts were as described 
previously [5]. For the Northern blot and run-on studies probes were 
used whtch cover most of the cDNA, i e for SI, a mix of cDNA clones 
S12 [I 31 and 11 [S], and for di~ptidylpeptldase IV. the rat liver cDP37 
clone [14], which was the only cDNA probe then available containing 
the whole codmg region of DPP IV and which showed a high level of 
homology to sequences available for human DPP IV [IS]. When nec- 
essary, the cDNA probes were “P-labelled accordmg to Femberg and 
Vogelstem [16] usmg a multtprime DNA labelling Kit (Amersham 
International. IJK). For the stability studtes of the mRNA, 5.6-dt- 
chloro-I-~-~-rlbofuranosyl ben~lmidiazole (DRB) (Calbiochem, 
France) was added on day 13 of culture to a final ~oncentratlon ofO.1 
mM from a stock solution of 0.1 M in dimethyl sulfoxide as described 
in 1171. At various times after the addition of DRB, total RNA was 
extracted from the cells and immobilized on filters using a slot-blot 
manifold (Schleicher and Schuell, Da&, Germany). After hybridtza- 
tion with “P-1abelled SI2 and 11 probes, the resultmg radIoactivity was 
quantified by Cerenkov countmg. Isolation of nuclet from control, 
forskolm- or monensin-treated Caco-2 cells, transcrIptiona ‘run-on’. 
extraction and quanti~~~tion f the 3LP-labelled RNA products were 
as described by Marzluff and Huang [t 81. Each transcription mixture 
contammg IO’ nuclei was divided into two samples which were either 
supplemented or not wtth a-amantm (final concentration, 1 l.tglml). 
The Z’P-labelled products from each transcription reaction sample 
were hybridized to two identical filters containing 13 yg of tmmobi- 
Iized denatured hnear plasmtd DNA containing the relevant probes 
(either SI or DPPIV). After 48 h of hybridization at 52°C. the filters 
were washed three times in 5 x SSC, 0.1% SDS, 1 mM EDTA, 10 mM 
Tris-HCl, pH 7.5, for 30 min at 52°C. once in 2 X SSC, 10 &ml 
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RNase A for 10 mm at 37°C and once in 2 x SSC for 10 mm at room 
temperature. 
3. RESULTS 
Based on the growth-related variation of sucrase ac- 
tivity [5] and SI mRNA levels (Fig. 1) experiments were 
performed between days 13 and 15, i.e. when the level 
of SI mRNA increases dramatically. 
Northern blot analysis of RNA (Fig. 2) confirmed the 
previously observed decrease of SI mRNA level after 48 
h of treatment with forskolin or monensin [5-S]. and 
showed that this decrease is already detectable after a 
24 h treatment. A similar level of a 4 kb DPP IV mes- 
sage was detected in both the control and treated cells, 
as previously reported using a 700 bp human DPP IV 
cDNA probe [7]. 
To determine the effectiveness of DRB in blocking 
the RNA polymerase II transcription, we monitored 
incorporation of [‘Hluridine into RNA from control, 
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Fig. 2. Northern blot analysis. Total RNA (10 pug) from Caco-2 cells 
(C) or Caco-2 cells treated with forskolin (FK) or monensm (M) for 
24 h (day 15) (A) or 48 h (day 16 (B) was fractionated on a 1% agarose 
gel. The membrane was probed with SI2 (SI) and cDP37 (DPP IV) 
h after addition of DRB, no [3H]uridine incorporation 
into RNA was detected whatever the treatment (not 
shown). The cells cultured 24 h in the presence of DRB 
were tested for their viability: after re-plating under 
standard culture conditions, no cellular mortality was 
observed. The timecourse of the decay of SI mRNA 
was measured by following the hybridization signal for 
24 h after DRB treatment (Fig. 3). The SI mRNA stabil- 
ity is about the same in the absence or in the presence 
of forskolin or monensin, and the half-life of Sl mRNA 
was estimated as 30 h. 
Preliminary transcription experiments on isolated nu- 
clei were performed using S12 alone as the SI cDNA 
probe, and the filters were washed at high stringency. 
In these experiments no hybridization of labelled RNA 
Fig. I. Growth-related vartattons of SI mRNA levels in Caco-2 cells. Fig. 3. Measurement of the stabthty of the SI mRNA. Total RNA (10 
(Upper panel) Northern blot analysts. Total RNA (25 pg) were ex- pug) were isolated from Caco-2 cells (m) or Caco-2 cells treated wtth 
tracted from Caco-2 cells after 5, 10 and I5 days m culture, separated forskolin (0) or monensin (A) at the indicated times after DRB addt- 
on a 1% agarose gel and hybridized with S12. (Lower panel) Densito- tion. After hybrtdizatton to the SI2 probe, the resultmg signals were 
metric analysis of the fluorogram. Note the large Increase of SI mRNA measured and expressed as the percentage of the initial value for each 
beween day 10 and day 15. condition 
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Ftg. 4. Nuclear run-on experiments. Transcription of SI (A) or DPP IV (B) in control (C). forskolin (FK)- or monensin (M)-treated cells analyzed 
after 48 h treatment (day 16) with (1) or without (2) a-amanitin. 
to the S12 probe could be detected. This was probably 
due to the small size of S12 as compared with the esti- 
mated length of the primary transcripts (55 kb) [8]. Two 
different modifications were then introduced into the 
protocol: (i) the use of a mixture of S12 and 11 as SI 
probes; (ii) the use of RNase A to reduce the non- 
specific hybridization of the 32P-labelled RNA products. 
The results of the nuclear run-on experiments shown 
in Fig. 4 demonstrate a reduction in the transcription 
rate of SI in both the forskolin- and monensin-treated 
Caco-2 cells. In the absence of ol-amanitin there is 4- to 
5-fold less signal in the treated cells than in the control 
cells, whereas the signals obtained for ]the DPP IV, used 
as an internal control, show the same intensity in each 
case. In the presence of ol-amanitin at 1 ,&ml, a concen- 
tration which specifically inhibits RNA polymerase II 
(Fig. 4A( 1) and Fig. 4B( l)), only trace amounts of 32P- 
labelled RNA hybridized with the SI or DPP IV probes. 
4. DISCUSSION 
We show in the present work that the variations in the 
steady-state level of SI mRNA between control and 
forskolin- or monensin-treated Caco-2 cells cannot be 
attributed to differences in mRNA stability but result 
from a decrease in transcription rate. It must be noted 
that, considering the estimated half-life of SI mRNA to 
be 30 h in all the conditions (Fig. 3), one would expect 
that the SI mRNA would decrease no more than about 
50% within 24 h of treatment with forskolin or monen- 
sin. This apparent discrepancy is most likely due in part 
to the fact that the beginning of the treatments were 
performed at a period of cell growth when the level of 
SI mRNA is considerably increasing in control cells 
(Fig. 1) thus exaggerating the differences. Furthermore 
it cannot be excluded that DRB treatment results in a 
stabilization of SI mRNA, through inhibiting RNase 
synthesis. If so, the half-life of SI mRNA could be over- 
estimated. The effect of both drugs appears to be spe- 
cific for SI, since the transcription rate of DPP IV, 
another brush border hydrolase, is not affected. 
The classical effect of monensin is post-translational 
and characterized by an impairment of the N-glycosyla- 
tion process [2]. It has never previously been reported 
to have an effect on the regulation of genes at the tran- 
scriptional level. Forskolin is commonly used to in- 
crease the intracellular CAMP via an activation of 
adenylate cyclase [l]. Such an increase in the CAMP 
level can in turn regulate the transcription of a number 
of genes through the consensus sequence, CRE [19]. The 
absence of this sequence in the 5’ region of the human 
gene [8,9], makes it unlikely that the transcription of SI 
is directly regulated via CAMP. 
Thus another mechanism is likely to explain the com- 
mon and apparently specific effect of forskolin and 
monensin on the transcription of the human SI gene in 
Caco-2 cells. It has been demonstrated that the inhibit- 
ing effect of these drugs on the expression of SI is always 
associated with increased glucose utilization in these 
cells: forskolin induces a decrease in intracellular glyco- 
gen content and an increased glucose consumption 
[3,5,7], and monensin induces an increase in the rate of 
glucose consumption [4,6.7]. Our previous results led us 
to hypothesize that glucose negatively interferes with 
the expression of SI at the transcriptional level. This was 
further supported by the results obtained with another 
human colon carcinoma cell line, HT-29. in which the 
SI mRNA level is detectable only when the cells are 
cultured in medium totally deprived of glucose [8]. 
Regulatory elements potentially responsible for the 
tissue-specific expression of SI have been identified 
[9,20] but nothing is known about the mechanisms in- 
volved in this hypothetical metabolic regulation. The 
results of the present work lend support to the idea that 
metabolic glucose repression of SI in Caco-2 cells is 
indeed achieved through regulatory elements in the SI 
gene, in a manner similar to that demonstrated for the 
human glucose-regulated proteins [2 11. 
That SI might be regulated by one of the products of 
the hydrolysis of sucrose is not entirely surprising, but 
whether the metabolic repression of SI observed in 
Caco-2 and HT-29 cells is a consequence of their malig- 
nant state remains to be elucidated. One piece of evi- 
dence that suggests that this mode of regulation might 
57 
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be relevant in normal tissue is the observation that the 
disappearance of SI in human fetal colon at mid-gesta- 
tion occurs at the same time as the decrease in accumu- 
lation of intracellular glycogen in intestinal epithelial 
cells [22]. 
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